Investigator Details
Jing Lin
Investigation Details
Last Issued Date
May 3, 2023
No. of 483’s Issued
since 2023
2
Warning Letters Issued
0
Detailed Analysis
Approach:
Investigator Jing Lin takes a meticulous approach to inspecting GMP compliance and quality systems, prioritizing the identification of deficiencies and non-compliance in manufacturing practices and testing procedures.
Profile:
Investigator Jing Lin is particularly focused on GMP compliance and quality systems in both drug substance and drug product manufacturing. He pays close attention to production and process controls, manufacturing practices, and quality control testing, and emphasizes adherence to standard protocols and regulations. He is concerned about potential risks in product safety and efficacy.
Top Process Types:
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now